Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

55%

6 of 11 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A
5(45.5%)
Phase 2
4(36.4%)
Phase 4
1(9.1%)
Phase 3
1(9.1%)
11Total
N/A(5)
Phase 2(4)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT03959696Not ApplicableCompleted

Promoting Informed Decisions About Cancer Screening in Older Adults

Role: collaborator

NCT00675935Not ApplicableCompleted

Falls - Tailoring Interventions for Patient Safety

Role: collaborator

NCT00146562Phase 2Completed

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Role: collaborator

NCT01714323Not ApplicableCompleted

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers

Role: collaborator

NCT01393704Phase 4Completed

Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial

Role: collaborator

NCT00908960Phase 2Completed

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles

Role: collaborator

NCT00483223Phase 2Completed

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Role: collaborator

NCT01791803Not ApplicableCompleted

Smoking Cessation After Hospitalization for a Cardiopulmonary Illness

Role: lead

NCT01070121Completed

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

Role: collaborator

NCT01583413Not ApplicableCompleted

CDC Prevention Epicenters Wake Up and Breathe Collaborative

Role: collaborator

NCT00916669Phase 2Withdrawn

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Role: collaborator

NCT00146549Phase 3Completed

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

Role: collaborator

All 12 trials loaded